Streetbeat News

Earnings

USPH

US Physical Therapy (NYSE:USPH) reported Q2 earnings of $0.76 per share, beating the analyst consensus estimate of $0.75 by 1.33%. However, this is a 15.56% decrease from the same period last year. The company also reported quarterly sales of $151.50 million, beating the estimate of $151.06 million by 0.29%, and marking a 7.71% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 9:06 pm

DOCS

Doximity has projected its FY23 revenue to be between $452M and $468M, which is lower than the estimated $501.63M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 9:06 pm

VRDN

Viridian Therapeutics reported Q2 losses of $(1.27) per share, beating the analyst consensus estimate of $(1.29) by 1.55 percent. However, this is a 19.81 percent decrease over losses from the same period last year. The company's quarterly sales of $72.00 thousand missed the analyst consensus estimate of $220.00 thousand by 67.27 percent, marking a 71.88 percent decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 9:05 pm

IRBT

IRobot Corporation has announced that it will continue to suspend its practice of providing full-year financial guidance.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 9:05 pm

DOCS

Doximity has projected its Q2 2023 revenue to be between $108.5M and $109.5M, which is lower than the estimated $121.35M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 9:05 pm

TYGO

Tigo Energy (NASDAQ:TYGO) reported Q2 earnings of $0.24 per share, in line with analyst consensus. However, the company's quarterly sales of $68.83 million missed the analyst consensus estimate of $71.93 million by 4.32 percent.

Portfolio Pulse from totan@benzinga.com

August 08, 2023 | 9:05 pm

SLF

Sun Life Financial reported Q2 earnings of $1.17 per share, missing the analyst consensus estimate of $1.18 by 0.93 percent. This represents a 1.76 percent decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 9:05 pm

DNMR

Danimer Scientific (NYSE:DNMR) reported Q2 losses of $(0.38) per share, missing the analyst consensus estimate of $(0.36) by 5.56%. This is a 26.67% decrease from the same period last year. The company also reported quarterly sales of $12.87 million, missing the analyst consensus estimate of $13.90 million by 7.45%. This is a 1.28% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 9:04 pm

HCAT

Health Catalyst (NASDAQ:HCAT) reported Q2 earnings of $0.05 per share, a 266.67% increase YoY. The company's quarterly sales were $73.21 million, beating the analyst consensus estimate of $72.63 million by 0.80% and marking a 3.65% increase over the same period last year.

Portfolio Pulse from mahesh@benzinga.com

August 08, 2023 | 9:04 pm

LGND

Ligand Pharmaceuticals reported Q2 earnings of $1.42 per share, beating the analyst consensus estimate of $0.64 by 121.87%. This is a 37.86% increase from the same period last year. The company also reported quarterly sales of $26.40 million, beating the analyst consensus estimate of $25.73 million by 2.60%. However, this is a 54.02% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 9:03 pm